Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheri L Spunt

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Psycho-Oncology|April 12, 2022
Smartphone-based Ecological Momentary Assessment to study "scanxiety" among Adolescent and Young Adult survivors of childhood cancer: A feasibility studyLauren C Heathcote, Sarah J Cunningham, Sarah N Webster, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2023
Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive ReviewMatthew M Poppe, An Tai, X Allen Li, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2009
Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcomaMatthew J Krasin, Andrew M Davidoff, Xiaoping Xiong, et al.
Pediatric Blood & Cancer|March 4, 2011
Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort studyMelissa M Hudson, Kirsten K Ness, Vikki G Nolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical TranslationMaryam Aghighi, Ashok J Theruvath, Anuj Pareek, et al.
Cancer|October 24, 2018
The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology GroupSuman Malempati, Brenda J Weigel, Yueh-Yun Chi, et al.
Cancer Medicine|August 29, 2019
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology GroupEmily Hibbitts, Yueh-Yun Chi, Douglas S Hawkins, et al.
Cancer Medicine|February 6, 2023
The significance of margins in pediatric Non-Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)Monika Sparber-Sauer, Andrea Ferrari, Sheri L Spunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumorsWayne L Furman, Fariba Navid, Najat C Daw, et al.
Cancer|April 3, 2024
Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332Sheri L Spunt, Wei Xue, Zhengya Gao, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Psycho-Oncology|April 12, 2022
Smartphone-based Ecological Momentary Assessment to study "scanxiety" among Adolescent and Young Adult survivors of childhood cancer: A feasibility studyLauren C Heathcote, Sarah J Cunningham, Sarah N Webster, et al.
International Journal of Radiation Oncology, Biology, Physics|July 15, 2023
Kidney Disease in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive ReviewMatthew M Poppe, An Tai, X Allen Li, et al.
International Journal of Radiation Oncology, Biology, Physics|July 24, 2009
Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcomaMatthew J Krasin, Andrew M Davidoff, Xiaoping Xiong, et al.
Pediatric Blood & Cancer|March 4, 2011
Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort studyMelissa M Hudson, Kirsten K Ness, Vikki G Nolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2018
Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical TranslationMaryam Aghighi, Ashok J Theruvath, Anuj Pareek, et al.
Cancer|October 24, 2018
The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology GroupSuman Malempati, Brenda J Weigel, Yueh-Yun Chi, et al.
Cancer Medicine|August 29, 2019
Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology GroupEmily Hibbitts, Yueh-Yun Chi, Douglas S Hawkins, et al.
Cancer Medicine|February 6, 2023
The significance of margins in pediatric Non-Rhabdomyosarcoma soft tissue sarcomas: Consensus on surgical margin definition harmonization from the INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT)Monika Sparber-Sauer, Andrea Ferrari, Sheri L Spunt, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2009
Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumorsWayne L Furman, Fariba Navid, Najat C Daw, et al.
Cancer|April 3, 2024
Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children's Oncology Group study ARST0332Sheri L Spunt, Wei Xue, Zhengya Gao, et al.
Pageof 17